Table 1 Antibodies used in this study
| Â | Host species | Dilution | Supplier | Application in this study |
|---|---|---|---|---|
Primary antibodies | ||||
 Anti-β-Tubulin class III | Rabbit | 1:1000 | Abcam, Melbourne, VIC, Australia | Cross sections |
 Anti-CD45 (clone IH-1) | Mouse | 1:200 | Abcam, Melbourne, VIC, Australia | Cross sections |
 Anti-choline acetyltransferase (ChAT) | Goat | 1:500 | Merck Millipore, Bayswater, Australia | LMMP preparations |
 Anti-Hu (clone 15A7.1) | Mouse | 1:500 | Merck Millipore, Bayswater, VIC, Australia | LMMP preparations |
 Anti-neuronal nitric oxide synthase (nNOS) | Goat | 1:500 | Novus Biologicals, Littleton, CO, USA | LMMP preparations |
 Anti-human leucocyte antigen (HLA)-A,B,C (conjugated to fluorescein isothiocyanate (FITC)) | Human | 1:50 | BioLegend, San Diego, CA, USA | Cross sections |
Secondary antibodies | ||||
 Alexa Fluor 594 | Donkey anti-mouse | 1:200 | Jackson Immunoresearch Labs, West Grove, PA, USA | LMMP preparations |
 Alexa Fluor 594 | Donkey anti-rabbit | 1:200 | Jackson Immunoresearch Labs, West Grove, PA, USA | Cross sections |
 FITC 488 | Donkey anti-goat | 1:200 | Jackson Immunoresearch Labs, West Grove, PA, USA | LMMP preparations |
 FITC 488 | Donkey anti-mouse | 1:200 | Jackson Immunoresearch Labs, West Grove, PA, USA | Cross sections |